基本信息
views: 20
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
I am a biotechnologist and my interests incline toward molecular imaging,specializing in use of positron emission tomography (PET) as a tool in preclinical evaluation of novel radiotracers for diabetes and pancreatic cancer. Also, I participate in other research groups for, in vivo imaging of affibodies and antibodies labeled with long lived SPECT or PET radionuclides for cancer research especially in breast cancer, prostate cancer and in head and neck squamous cell carcinomas.
At Preclinical PET Platform, I am investigating the possibilities for in vivo visualization and quantification of native pancreatic beta cell mass using PET as molecular imaging modality.
Research routines are preclinical oriented with use of
* Short lived positron emitting radionuclide such as [11C] ,[18F] & [68Ga]
* Long lived SPECT radionuclides such as [99mTc], [111In] & [177Lu]
* Human islets and cancer cell lines of pancreatic origin.
* Autoradiography
* Small Animal models
* In Vivo Imaging in small animals with PET-CT and SPECT-CT
* Image analysis using software’s such as PMOD, AMIRA, AMIDE and Image J
" Basic Kinetic Modeling.
Memberships
*Society of Nuclear Medicine
*European Association of Nuclear Medicine
Research Interests
Papers共 76 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Nuclear Medicine and Biology (2022): 62-71
P Nordeman,Z P Jayendra, E Briard, C Li S,M Larhed,G Antoni, S Estrada,R Selvaraju,O Åberg, M Rugaard Jensen,P Stålberg,B Skogseid,
Cited0Views0Bibtex
0
0
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn